Brooklyn Immunotherapeutics Inc
Change company Symbol lookup
Select an option...
BTX Brooklyn Immunotherapeutics Inc
SBCF Seacoast Banking Corporation of Florida
MSSAU Metal Sky Star Acquisition Corp
SDGR Schrodinger Inc
GPC Genuine Parts Co
VENA Venus Acquisition Corp
VECO Veeco Instruments Inc
IGTAU Inception Growth Acquisition Ltd
BAC-K Bank of America Corp
FAX abrdn Asia-Pacific Income Fund Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology |
Company profile

Brooklyn ImmunoTherapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cytokine-based therapies for treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Its lead product candidate, IRX-2, is a cytokine therapy, to treat patients with head and neck cancer. IRX-2 is a mixed, human-derived cytokine product with multiple active constituents including Interleukin-2 (IL2) and other key cytokines, which restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells. The Company also has multiple cell and gene-editing therapies in preclinical development for various indications, including acute respiratory distress syndrome, solid tumor indications, as well as in vivo gene-editing therapies for rare genetic diseases. Its subsidiaries include Brooklyn ImmunoTherapeutics LLC, Novellus, Inc. and Novellus Therapeutics, Ltd.

Closing Price
$0.2303
Day's Change
-0.0319 (-12.17%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.2993
Day's Low
0.2303
Volume
(Heavy Day)
Volume:
1,727,500

10-day average volume:
815,612
1,727,500

Lucid Announces Second Quarter 2022 Financial Results, Reports Strong Demand While Lowering Production Guidance for the Year

4:05 pm ET August 3, 2022 (PR Newswire) Print

-- Q2 revenue of $97.3M driven by customer deliveries of 679 vehicles in the quarter

-- Strong demand with over 37,000 reservations, representing potential sales of approximately $3.5B

-- Production volume outlook for 2022 revised to a range of 6,000 to 7,000 vehicles

Lucid Group, Inc. (NASDAQ: LCID), setting new standards with the longest-range, fastest-charging electric car on the market, today announced financial results for its second quarter ended June 30, 2022. Lucid reported Q2 revenue of $97.3 million on deliveries of 679 vehicles. The Company reported strong customer demand for Lucid Air with reservations over 37,000 as of today, representing potential sales of approximately $3.5 billion. Lucid revised its 2022 production volume outlook to a range of 6,000 to 7,000 vehicles. Lucid ended the quarter with $4.6 billion cash, cash equivalents, and investments, which is expected to fund the Company well into 2023. In addition, Lucid reported first half production of 1,405 vehicles.

https://mma.prnewswire.com/media/1080273/LucidMotors_Logo.jpg

"Our revised production guidance reflects the extraordinary supply chain and logistics challenges we encountered," said Peter Rawlinson, Lucid's CEO and CTO. "We've identified the primary bottlenecks, and we are taking appropriate measures - bringing our logistics operations in-house, adding key hires to the executive team, and restructuring our logistics and manufacturing organization. We continue to see strong demand for our vehicles, with over 37,000 customer reservations, and I remain confident that we shall overcome these near-term challenges."

"Our Q2 revenue was $97.3 million, primarily driven by higher customer deliveries of Lucid Air vehicles. We continue to have a strong balance sheet, closing the quarter with $4.6 billion cash, cash equivalents and investments, which we believe is sufficient to fund the Company well into 2023," said Sherry House, Lucid's CFO. "Despite our immediate challenges, we believe that bringing our logistics center on-site at our Arizona factory will help reduce complexity, cut down lead times, and reduce various costs."

Lucid will host a conference call for analysts and investors at 2:30 P.M. PT / 5:30 P.M. ET on August 3, 2022. The live webcast of the conference call will be available on the Investor Relations website at ir.lucidmotors.com. Following the completion of the call, a replay will be available on the same website. Lucid uses its ir.lucidmotors.com website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

About Lucid Group

Lucid's mission is to inspire the adoption of sustainable energy by creating advanced technologies and the most captivating luxury electric vehicles centered around the human experience. The Company's first car, Lucid Air, is a state-of-the-art luxury sedan with a California-inspired design that features luxurious full-size interior space in a mid-size exterior footprint. Underpinned by race-proven battery technology and proprietary powertrains developed entirely in-house, Lucid Air was named the 2022 MotorTrend Car of the Year(R). The Lucid Air Grand Touring features an official EPA estimated 516 miles of range or 1,050 horsepower. Deliveries of Lucid Air, which is produced at Lucid's factory in Casa Grande, Arizona, are currently underway to U.S. customers.

Investor Relations Contact

investor@lucidmotors.com

Media Contact

media@lucidmotors.com

Trademarks

This communication contains trademarks, service marks, trade names and copyrights of Lucid Group, Inc. and its subsidiaries and other companies, which are the property of their respective owners.

Forward Looking Statements

This communication includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "estimate," "plan," "project," "forecast," "intend," "will," "shall," "expect," "anticipate," "believe," "seek," "target," "continue," "could," "may," "might," "possible," "potential," "predict" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding financial and operating outlook, amount of reservations and related potential sales, future capital expenditures and other operating expenses, expectations and timing related to commercial product launches, including the Project Gravity SUV and the various Air models, production and delivery volumes, the range and performance of Lucid's vehicles, Lucid's estimate of the length of time its existing cash, cash equivalents and investments will be sufficient to fund planned operations, the timing of deliveries, future manufacturing capabilities and facilities, studio and service center openings, ability to mitigate supply chain and logistics risks, benefits of relocating Lucid's logistics operations center, ability to vertically integrate production processes, future sales channels and strategies, future market launches and international expansion, including Lucid's launch plans for the European market and planned manufacturing facility in Saudi Arabia, Lucid Financial Services, the potential success of Lucid's go-to-market strategy and future vehicle programs, and the promise of Lucid's technology. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Lucid's management. These forward-looking statements are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and may differ from these forward-looking statements. Many actual events and circumstances are beyond the control of Lucid. These forward-looking statements are subject to a number of risks and uncertainties, including changes in domestic and foreign business, market, financial, political and legal conditions, including the ongoing conflict between Russia and Ukraine; risks related to prices and availability of commodities, Lucid's supply chain, logistics, inventory management and quality control, and Lucid's ability to complete the tooling of its manufacturing facilities over time and scale production of the Lucid Air and other vehicles; risks related to the uncertainty of Lucid's projected financial information; risks related to the timing of expected business milestones and commercial product launches, including Lucid's ability to mass produce the Lucid Air and complete the tooling of its manufacturing facility; risks related to the expansion of Lucid's manufacturing facility, the construction of new manufacturing facilities and the increase of Lucid's production capacity; Lucid's ability to manage expenses; risks related to future market adoption of Lucid's offerings; the effects of competition and the pace and depth of electric vehicle adoption generally on Lucid's future business; changes in regulatory requirements, governmental incentives and fuel and energy prices; Lucid's ability to rapidly innovate; Lucid's ability to enter into or maintain partnerships with original equipment manufacturers, vendors and technology providers; Lucid's ability to effectively manage its growth and recruit and retain key employees, including its chief executive officer and executive team; risks related to potential vehicle recalls; Lucid's ability to establish and expand its brand and capture additional market share, and the risks associated with negative press or reputational harm; Lucid's ability to effectively utilize zero emission vehicle credits and obtain and utilize certain tax and other incentives; Lucid's ability to issue equity or equity-linked securities in the future; Lucid's ability to pay interest and principal on its indebtedness; future changes to vehicle specifications which may impact performance, pricing and other expectations; the outcome of any potential litigation, government and regulatory proceedings, investigations and inquiries; and the impact of the global COVID-19 pandemic on Lucid's supply chain, including COVID-related shutdowns of Lucid's suppliers' facilities in China, projected results of operations, financial performance or other financial metrics, or on any of the foregoing risks; and those factors discussed under the heading "Risk Factors" in Part II, Item 1A of Lucid's Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, as well as other documents Lucid has filed or will file with the Securities and Exchange Commission. If any of these risks materialize or Lucid's assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Lucid currently does not know or that Lucid currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Lucid's expectations, plans or forecasts of future events and views as of the date of this communication. Lucid anticipates that subsequent events and developments will cause Lucid's assessments to change. However, while Lucid may elect to update these forward-looking statements at some point in the future, Lucid specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Lucid's assessments as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Non-GAAP Financial Measures and Key Business Metrics:

Condensed consolidated financial information has been presented in accordance with US GAAP ("GAAP") as well as on a non-GAAP basis to supplement our condensed consolidated financial results. Lucid's non-GAAP financial measures include Adjusted EBITDA and Free Cash Flow which are discussed below.

Adjusted EBITDA is defined as net loss before (1) interest expense, (2) interest income, (3) provision for income taxes, (4) depreciation and amortization, (5) change in fair value of forward contracts, (6) change in fair value of convertible preferred stock warrant liability, (7) change in fair value of common stock warrant liability and (8) stock-based compensation. Adjusted EBITDA is a performance measure that Lucid believes provides useful information to Lucid's management and investors about Lucid's profitability. Free Cash Flow is defined as net cash used in operating activities reduced by capital expenditures. Free Cash Flow is a performance measure that Lucid believes provides useful information to Lucid's management and investors about the amount of cash generated by the business after necessary capital expenditures.

These non-GAAP financial measures facilitate management's internal comparisons to Lucid's historical performance. Management believes that it is useful to supplement its GAAP financial statements with this non-GAAP information because management uses such information internally for its operating, budgeting, and financial planning purposes. Management also believes that presentation of the non-GAAP financial measures provides useful information to Lucid's investors regarding measures of our financial condition and results of operations that Lucid uses to run the business and therefore allows investors to better understand Lucid's performance. However, these non-GAAP financial and key performance measures have limitations as analytical tools and you should not consider them in isolation or as substitutes for analysis of our results as reported under GAAP.

Non-GAAP information is not prepared under a comprehensive set of accounting rules and therefore, should only be read in conjunction with financial information reported under GAAP when understanding Lucid's operating performance. In addition, other companies, including companies in our industry, may calculate non-GAAP financial measures and key performance measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures and key performance measures as tools for comparison. A reconciliation between GAAP and non-GAAP financial information is presented below.

LUCID GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS1
Unaudited
(in thousands, except share and per share data)
                                                                                               June 30,           December 31,
                                                                                               2022               2021
ASSETS
Current assets:
Cash and cash equivalents                                                                      $      3,157,449   $      6,262,905
Short-term investments                                                                         1,136,633          --
Accounts receivable, net                                                                       1,294              3,148
Inventory                                                                                      553,045            127,250
Prepaid expenses                                                                               48,963             70,346
Other current assets                                                                           69,105             43,328
Total current assets                                                                           4,966,489          6,506,977
Property, plant and equipment, net                                                             1,615,435          1,182,153
Right-of-use assets                                                                            198,207            161,974
Long-term investments                                                                          278,055            --
Other noncurrent assets                                                                        71,233             30,609
TOTAL ASSETS                                                                                   $      7,129,419   $      7,881,713
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable                                                                               $         129,070  $           41,342
Accrued compensation                                                                           55,550             32,364
Finance lease liabilities, current portion                                                     4,657              4,183
Other current liabilities                                                                      464,819            318,212
Total current liabilities                                                                      654,096            396,101
Finance lease liabilities, net of current portion                                              5,377              6,083
Common stock warrant liability                                                                 536,635            1,394,808
Long-term debt                                                                                 1,989,200          1,986,791
Other long-term liabilities                                                                    233,725            188,575
Total liabilities                                                                              3,419,033          3,972,358
STOCKHOLDERS' EQUITY
Preferred stock, par value $0.0001; 10,000,000 shares authorized as of June 30, 2022 and       --                 --
December 31, 2021; no shares issued and outstanding as of June 30, 2022 and December 31, 2021
Common stock, par value $0.0001; 15,000,000,000 shares authorized as of June 30, 2022 and      167                165
December 31, 2021; 1,673,401,436 and 1,648,413,415 shares issued and 1,672,543,611 and
1,647,555,590 shares outstanding as of June 30, 2022 and December 31, 2021, respectively
Additional paid-in capital                                                                     10,099,209         9,995,778
Treasury stock, at cost, 857,825 shares at June 30, 2022 and December 31, 2021                 (20,716)           (20,716)
Accumulated other comprehensive loss                                                           (691)              --
Accumulated deficit                                                                            (6,367,583)        (6,065,872)
Total stockholders' equity                                                                     3,710,386          3,909,355
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                                     $      7,129,419   $      7,881,713
LUCID GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS1
Unaudited
(in thousands, except share and per share data)
                                                                          Three Months Ended                           Six Months Ended
                                                                          June 30,                                     June 30,
                                                                          2022                  2021                   2022                  2021
Revenue                                                                   $          97,336     $                174   $        155,011      $                   487
Costs and expenses
Cost of revenue                                                           292,342               19                     538,312               104
Research and development                                                  200,381               176,802                386,457               344,171
Selling, general and administrative                                       163,812               72,272                 386,971               203,924
Total cost and expenses                                                   656,535               249,093                1,311,740             548,199
Loss from operations                                                      (559,199)             (248,919)              (1,156,729)           (547,712)
Other income (expense), net
Change in fair value of forward contracts                                 --                    (12,382)               --                    (454,546)
Change in fair value of convertible preferred stock warrant liability     --                    --                     --                    (6,976)
Change in fair value of common stock warrant liability                    334,843               --                     858,173               --
Interest expense                                                          (7,189)               (30)                   (14,908)              (35)
Other income (expense), net                                               11,188                (390)                  12,144                (400)
Total other income (expense), net                                         338,842               (12,802)               855,409               (461,957)
Loss before provision for income taxes                                    (220,357)             (261,721)              (301,320)             (1,009,669)
Provision for income taxes                                                68                    5                      391                   9
Net loss                                                                  (220,425)             (261,726)              (301,711)             (1,009,678)
Deemed dividend related to the issuance of Series E convertible preferred --                    --                     --                    (2,167,332)
stock
Net loss attributable to common stockholders, basic                       (220,425)             (261,726)              (301,711)             (3,177,010)
Change in fair value of dilutive warrants                                 (334,843)             --                     (858,173)             --
Net loss attributable to common stockholders, diluted                     $      (555,268)      $      (261,726)       $   (1,159,884)       $       (3,177,010)
Weighted average shares outstanding used in computing net loss per share  1,669,303,813         36,298,508             1,661,960,471         34,484,767
attributable to common stockholders, basic
Weighted average shares outstanding used in computing net loss per share  1,686,815,404         36,298,508             1,684,328,007         34,484,767
attributable to common stockholders, diluted
Net loss per share attributable to common stockholders, basic             $             (0.13)  $             (7.21)   $             (0.18)  $               (92.13)
Net loss per share attributable to common stockholders, diluted           $             (0.33)  $             (7.21)   $             (0.69)  $               (92.13)
Other comprehensive loss
Net unrealized losses on investments, net of tax                          $              (691)  $                  --  $              (691)  $                      --
Comprehensive loss                                                        (221,116)             (261,726)              (302,402)             (1,009,678)
Deemed dividend related to the issuance of Series E convertible preferred --                    --                     --                    (2,167,332)
stock
Comprehensive loss attributable to common stockholders                    $      (221,116)      $      (261,726)       $      (302,402)      $       (3,177,010)
LUCID GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS1
Unaudited
(in thousands)
                                                                            Three Months Ended                  Six Months Ended
                                                                            June 30,                            June 30,
                                                                            2022            2021                2022                2021
Cash flows from operating activities
Net loss                                                                    $    (220,425)  $        (261,726)  $        (301,711)  $    (1,009,678)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization                                               42,448          6,819               80,690              11,738
Amortization of insurance premium                                           7,425           2,747               14,924              2,747
Non-cash operating lease cost                                               4,848           7,206               8,952               13,502
Stock-based compensation                                                    94,392          24,449              268,943             129,244
Amortization of debt discounts and issuance costs                           1,154           --                  2,409               --
Inventory write-downs                                                       81,691          --                  178,057             --
Change in fair value of contingent forward contract liability               --              12,382              --                  454,546
Change in fair value of preferred stock warrant liability                   --              --                  --                  6,976
Change in fair value of common stock warrant liability                      (334,843)       --                  (858,173)           --
Other non-cash items                                                        (5)             --                  (5)                 56
Changes in operating assets and liabilities:
Accounts receivable                                                         (673)           158                 1,608               (220)
Inventory                                                                   (300,830)       (21,914)            (603,852)           (27,181)
Prepaid expenses                                                            (14,064)        (18,401)            6,459               (22,183)
Other current assets                                                        17,426          (1,836)             (32,199)            (2,380)
Other noncurrent assets                                                     (16,381)        (971)               (27,556)            (3,870)
Accounts payable                                                            43,883          2,673               49,596              (11,871)
Accrued compensation                                                        26,793          4,344               23,186              7,990
Operating lease liability                                                   (3,845)         (3,643)             (6,944)             (7,742)
Other current liabilities                                                   51,484          11,757              179,544             633
Other long-term liabilities                                                 5,894           878                 7,795               3,889
Net cash used in operating activities                                       (513,628)       (235,078)           (1,008,277)         (453,804)
Cash flows from investing activities:
Purchases of property, plant and equipment                                  (309,818)       (111,754)           (494,900)           (206,533)
Proceed from sale of property, plant and equipment                          --              19                  --                  19
Purchases of investments                                                    (1,419,223)     --                  (1,419,223)         --
Net cash used in investing activities                                       (1,729,041)     (111,735)           (1,914,123)         (206,514)
Cash flows from financing activities:
Payment for short-term insurance financing note                             (2,381)         (2,747)             (15,330)            (2,747)
Payment for finance lease liabilities                                       (1,200)         (1,066)             (2,401)             (1,364)
Proceeds from short-term insurance financing note                           --              10,950              --                  10,950
Proceeds from borrowings                                                    6,663           --                  6,663               --
Repurchase of Series B convertible preferred stock                          --              --                  --                  (3,000)
Proceeds from issuance of Series D convertible preferred stock              --              --                  --                  3,000
Proceeds from issuance of Series E convertible preferred stock              --              92,920              --                  600,000
Proceeds from exercise of stock options                                     3,735           950                 12,849              5,266
Proceeds from employee stock purchase plan                                  12,882          --                  12,882              --
Stock repurchases from employees for tax withholdings                       (8,976)         --                  (191,241)           --
Payment for credit facility issuance costs                                  (6,631)         --                  (6,631)             --
Net cash provided by (used in) financing activities                         4,092           101,007             (183,209)           612,105
Net decrease in cash, cash equivalents, and restricted cash                 (2,238,577)     (245,806)           (3,105,609)         (48,213)
Beginning cash, cash equivalents, and restricted cash                       5,430,988       838,011             6,298,020           640,418
Ending cash, cash equivalents, and restricted cash                          $  3,192,411    $         592,205   $      3,192,411    $         592,205
LUCID GROUP, INC.
Reconciliation of GAAP to Non-GAAP Financials Measures1
Unaudited
(in thousands)
Adjusted EBITDA
                                                                      Three Months Ended              Six Months Ended
                                                                      June 30,                        June 30,
                                                                      2022            2021            2022            2021
Net loss (GAAP)                                                       $    (220,425)  $    (261,726)  $    (301,711)  $ (1,009,678)
Interest expense                                                      7,189           30              14,908          35
Interest income                                                       (2,911)         --              (2,911)         --
Provision for income taxes                                            68              5               391             9
Depreciation and amortization                                         42,448          6,819           80,690          11,738
Change in fair value of forward contracts                             --              12,382          --              454,546
Change in fair value of convertible preferred stock warrant liability --              --              --              6,976
Change in fair value of common stock warrant liability                (334,843)       --              (858,173)       --
Stock-based compensation                                              94,392          24,449          268,943         129,244
Adjusted EBITDA (non-GAAP)                                            $    (414,082)  $    (218,041)  $    (797,863)  $    (407,130)
Free Cash Flow
                                                                      Three Months Ended              Six Months Ended
                                                                      June 30,                        June 30,
                                                                      2022            2021            2022            2021
Net cash used in operating activities (GAAP)                          $    (513,628)  $    (235,078)  $ (1,008,277)   $    (453,804)
Capital expenditures                                                  (309,818)       (111,754)       (494,900)       (206,533)
Free cash flow (non-GAAP)                                             $    (823,446)  $    (346,832)  $ (1,503,177)   $    (660,337)
___________________________________
1 The business combination (the "Merger") between Lucid Group Inc.'s predecessor, Atieva, Inc. ("Legacy Lucid"), and Churchill Capital Corp IV ("CCIV"), which closed on July 23, 2021, is accounted for as a reverse recapitalization under U.S. GAAP. Under this method of accounting, CCIV has been treated as the acquired company for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of Lucid represent a continuation of the financial statements of Legacy Lucid with the Merger being treated as the equivalent of Legacy Lucid issuing shares for the net assets of CCIV, accompanied by a recapitalization. The net assets of CCIV were recognized as of the closing of the Merger at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger are presented as those of Legacy Lucid and the accumulated deficit of Legacy Lucid has been carried forward after the closing of the Merger. All periods prior to the Merger have been retrospectively adjusted using the applicable exchange ratio for the equivalent number of shares outstanding immediately after the closing of the Merger to effect the reverse recapitalization. See our Form 10-Q for the three and six months ended June 30, 2022 for additional information.

https://c212.net/c/img/favicon.png?sn=SF35729&sd=2022-08-03

View original content to download multimedia:https://www.prnewswire.com/news-releases/lucid-announces-second-quarter-2022-financial-results-reports-strong-demand-while-lowering-production-guidance-for-the-year-301599377.html

SOURCE Lucid Group

https://rt.prnewswire.com/rt.gif?NewsItemId=SF35729&Transmission_Id=202208031605PR_NEWS_USPR_____SF35729&DateId=20220803

comtex tracking

COMTEX_411519752/1005/2022-08-03T16:05:49

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.